- Conditions
- Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- National Kyusyu Cancer Center Fukuoka, Japan
- Imamura Bun-in Hospital Kagoshima, Japan
- Kumamoto University Hospital Kumamoto, Japan
- Nagasaki University Hospital Nagasaki, Japan
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
239 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
NCT01822886
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, Italy
- Istituto di Ematologia ed Oncologia Medica A. Seragnoli Policlinico S. Orsola Bologna, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- A.O. Universitaria Citta' Della Salute E Della Scienza Di Torino Torino, Italy
NCT03349333
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
NCT01529827
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Completed
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NCT01839916
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT02809573
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Completed
T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
NCT01142674
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Stanford University Medical Center Palo Alto, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- St Louis Washington University St Louis, Missouri, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT01164709
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
- Locations
-
- Inselspital Bern Bern, Switzerland
- Kantonsspital Graubuenden Chur, Switzerland
- Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland
- Kantonsspital - St. Gallen Sankt Gallen, Switzerland
Completed
Alemtuzumab and CHOP in T-cell Lymphoma
NCT00646854
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- AKH Linz Linz, Austria
- Krankenhaus der Elisabethinen Linz, Austria
- Center for Clinical Cancer and Immunology Trials Salzburg, Austria
- Hanusch Krankenhaus Vienna, Austria
NCT01456039
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Nagoya Daini Red Cross Hospital Nagoya, Aichi-ken, Japan
- Nagoya City University Hospital Nagoya, Aichi-ken, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- Ehime University Hospital Tōon, Ehime, Japan